Restrictions on obesity drug coverage force patients to pivot

Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, according to an analysis by GoodRx, a drug discount website.(Image credit: Jodi Hilton for NPR)